Benjamin L. Schlechter

1.2k total citations
51 papers, 655 citations indexed

About

Benjamin L. Schlechter is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin L. Schlechter has authored 51 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 13 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin L. Schlechter's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Benjamin L. Schlechter is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Benjamin L. Schlechter collaborates with scholars based in United States, Canada and United Kingdom. Benjamin L. Schlechter's co-authors include Carol L. Rosenberg, Antonio de las Morenas, Bahman Guyuron, Qiong Yang, Mäneka Puligandla, Jeffrey L. Ponsky, Donna Neuberg, Jeffrey I. Zwicker, Geraldine A. Hamilton and Angela Lai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Benjamin L. Schlechter

48 papers receiving 644 citations

Peers

Benjamin L. Schlechter

ONCOL

SURGE

PRM

Hongjie Guo China

Qi Shen China

Jiancong Hu China

Gerardo Flammia Italy

Tsuyoshi Mori Japan

Roxana Coras United States

Rosemarie Kiefl Germany

Ümit Zeybek Türkiye

Shusen Zheng China

Hongjie Guo China

Benjamin L. Schlechter

200 ×1.0

ONCOL

109 ×0.7

SURGE

311 ×2.0

113 ×1.1

105 ×1.1

PRM

Citations per year, relative to Benjamin L. Schlechter Benjamin L. Schlechter (= 1×) peers Hongjie Guo

Countries citing papers authored by Benjamin L. Schlechter

Since Specialization

Citations

This map shows the geographic impact of Benjamin L. Schlechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Schlechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Schlechter more than expected).

Fields of papers citing papers by Benjamin L. Schlechter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Schlechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Schlechter. The network helps show where Benjamin L. Schlechter may publish in the future.

Co-authorship network of co-authors of Benjamin L. Schlechter

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin L. Schlechter. A scholar is included among the top collaborators of Benjamin L. Schlechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin L. Schlechter. Benjamin L. Schlechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dumbrava, Ecaterina E., Syma Iqbal, Gregory P. Botta, et al.. (2025). A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2+ advanced solid tumors.. Journal of Clinical Oncology. 43(4_suppl). 828–828.

Keenan, Bridget P., Christopher H. Lieu, Marwan Fakih, et al.. (2025). A phase 1 dose-escalation study of GCC19CART: A novel CAR T-cell therapy for metastatic colorectal cancer in the United States.. Journal of Clinical Oncology. 43(4_suppl). 175–175. 1 indexed citations

Fakih, Marwan, Neil H. Segal, Benjamin L. Schlechter, et al.. (2025). Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).. Journal of Clinical Oncology. 43(4_suppl). 23–23. 2 indexed citations

Coveler, Andrew L., Benjamin L. Schlechter, Tanios Bekaii‐Saab, et al.. (2024). A multicenter phase Ia study of AbGn-107, a novel antibody–drug conjugate, in patients with advanced gastrointestinal cancer. Investigational New Drugs. 42(2). 221–228. 1 indexed citations

Schlechter, Benjamin L., Ecaterina E. Dumbrava, Samuel D. Saibil, et al.. (2024). A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors.. Journal of Clinical Oncology. 42(3_suppl). 747–747. 2 indexed citations

Olson, Daniel J., Ecaterina E. Dumbrava, Syma Iqbal, et al.. (2023). 738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors. SHILAP Revista de lepidopterología. A831–A831. 1 indexed citations

Koenig, Julie L., Beow Y. Yeap, Jeffrey W. Clark, et al.. (2023). A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4143–4143. 2 indexed citations

Dumbrava, Ecaterina E., Daniel J. Olson, Samuel D. Saibil, et al.. (2023). Abstract CT234: A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors. Cancer Research. 83(8_Supplement). CT234–CT234. 1 indexed citations

Cutsem, E. Van, Marwan Fakih, Neil H. Segal, et al.. (2023). 116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer. Immuno-Oncology Technology. 20. 100588–100588. 1 indexed citations

10.

Huffman, Brandon M., Atrayee Basu Mallick, Nora Horick, et al.. (2023). Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma. JAMA Network Open. 6(1). e2249720–e2249720. 8 indexed citations

11.

Allar, Benjamin G., Evangelos Messaris, Vitaliy Poylin, Benjamin L. Schlechter, & Thomas E. Cataldo. (2022). Oncotype DX testing does not affect clinical practice in stage IIa colon cancer. Medical Oncology. 39(5). 59–59. 3 indexed citations

12.

Zwicker, Jeffrey I., Mäneka Puligandla, Benjamin L. Schlechter, et al.. (2020). Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Advances. 4(10). 2254–2260. 16 indexed citations

13.

Zwicker, Jeffrey I., Benjamin L. Schlechter, Jack D. Stopa, et al.. (2019). Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 4(4). 128 indexed citations

14.

Jain, Abhishek, Andries D. van der Meer, Anne‐Laure Papa, et al.. (2016). Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomedical Microdevices. 18(4). 73–73. 112 indexed citations

15.

Schlechter, Benjamin L., et al.. (2008). CDKN1C/p57kip2is a candidate tumor suppressor gene in human breast cancer. BMC Cancer. 8(1). 68–68. 46 indexed citations

16.

Weinzweig, Norman, Benjamin L. Schlechter, Henry Baraniewski, & James J. Schuler. (1997). Lower-Limb Salvage in a Patient with Recalcitrant Venous Ulcerations. Journal of Reconstructive Microsurgery. 13(6). 431–437. 8 indexed citations

17.

Schlechter, Benjamin L. & Bahman Guyuron. (1994). A Comparison of Different Suture Techniques for Microvascular Anastomosis. Annals of Plastic Surgery. 33(1). 28–31. 31 indexed citations

18.

Schlechter, Benjamin L., et al.. (1994). Intraabdominal mesh prosthesis in a canine model. Surgical Endoscopy. 8(2). 127–129. 10 indexed citations

19.

Mellinger, John D., et al.. (1991). Tract formation following percutaneous endoscopic gastrostomy in an animal model. Surgical Endoscopy. 5(4). 189–191. 35 indexed citations

20.

Guyuron, Bahman & Benjamin L. Schlechter. (1990). Pseudomeningocele as a Complication of Teratoma Resection and Aseptic Meningitis Following Craniofacial Reconstruction. Journal of Craniofacial Surgery. 1(4). 179–181. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact